First Time Loading...

Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.105 CAD -8.7% Market Closed
Updated: May 4, 2024

Valeo Pharma Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Valeo Pharma Inc
Net Income (Common) Peer Comparison

Comparables:
BHC
TH
K
GUD
EDT
CPH

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Valeo Pharma Inc
TSX:VPH
Net Income (Common)
-CA$27.8m
CAGR 3-Years
-80%
CAGR 5-Years
-63%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Net Income (Common)
-$592m
CAGR 3-Years
-2%
CAGR 5-Years
32%
CAGR 10-Years
4%
Theratechnologies Inc
TSX:TH
Net Income (Common)
-$18m
CAGR 3-Years
9%
CAGR 5-Years
-36%
CAGR 10-Years
-7%
K
Knight Therapeutics Inc
TSX:GUD
Net Income (Common)
-CA$16.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Net Income (Common)
-CA$15.7m
CAGR 3-Years
-20%
CAGR 5-Years
-44%
CAGR 10-Years
-3%
Cipher Pharmaceuticals Inc
TSX:CPH
Net Income (Common)
$20.4m
CAGR 3-Years
65%
CAGR 5-Years
107%
CAGR 10-Years
-2%

See Also

What is Valeo Pharma Inc's Net Income (Common)?
Net Income (Common)
-27.8m CAD

Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Net Income (Common) amounts to -27.8m CAD.

What is Valeo Pharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-63%

Over the last year, the Net Income (Common) growth was -8%. The average annual Net Income (Common) growth rates for Valeo Pharma Inc have been -80% over the past three years , -63% over the past five years .